WebApr 12, 2024 · The use of pholcodine-containing medicines, up to 12 months before surgery, increases the risk of anaphylactic reaction in patients who receive NMBAs. Effective measures to minimise the risk of anaphylactic reactions to NMBAs, or to identify a patient population for whom the benefits of pholcodine outweigh its risks, have not yet been … WebMar 14, 2024 · The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Pholcodine-containing products (Various Marketing Authorisation Holders) Following the conclusion of a review of post-marketing safety data by the MHRA, all pholcodine-containing medicines are being recalled and withdrawn from …
Cough medicine recall list: Which products containing …
WebMar 15, 2024 · The opioid medicine, which is used in 20 common over-the-counter cough medicines such as Day & Night Nurse and Boots Day Cold & Flu Relief, is understood to increase the risk of “very rare” allergic reactions to neuromuscular blocking agents (NMBAs) used in general anaesthesia during surgery. WebApr 15, 2024 · The risk of anaphylactic reactions to neuromuscular blocking agents (NMBAs) in people with prior use of pholcodine-containing cough and cold medicines has been highlighted in a safety alert by the World Health Organization (WHO). In the safety alert issued 31 March 2024, healthcare professionals and regulatory authorities are alerted to … dhs rights and responsibilities illinois
Cough medicine recall list: Which products containing pholcodine …
WebApr 15, 2024 · The Medicines Control Authority of Zimbabwe (MCAZ) has halted the use of medicines containing the pholcodine substance after learning it causes life threatening … WebDec 2, 2024 · Pholcodine is an opioid medicine that is used in adults and children for the treatment of non-productive (dry) cough and, in combination with other active substances, … WebAnaesthetists in Australia and New Zealand are campaigning for pholcodine-containing cough medicines to become prescription-only products. The call follows fresh concerns that the medicines may trigger a potentially fatal anaphylactic reaction … dhs risk based performance standards